Journals / İzmir Dr. Behçet Uz Çocuk Hastanesi Dergisi / 2014 / Cilt: 4 - Sayı: 1

Antibiotic resistance in childhood Helicobacter pylori infection

Çocukluk çağı Helicobacter pylori infeksiyonunda antibiyotik direnci

Pages
10–14
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Determination of the antibiotic resistance is important in planning the treatment and in obtaining higher eradication rates.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In recent years, cure rates of Helicobacter pylori eradication therapies have been decreased.
📊
Key Findings & Data:Resistance to the antibiotics used is the most important cause of this decline.
💡
Conclusion & Impact:Determination of the antibiotic resistance is important in planning the treatment and in obtaining higher eradication rates.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In recent years, cure rates of Helicobacter pylori eradication therapies have been decreased. Resistance to the antibiotics used is the most important cause of this decline. Point mutations and drug excreting proteins play important roles in drug resistance mechanisms. The resistance to the antibiotics used in pediatric Helicobacter pylori eradication (clarithromycin, metronidazole and amoxicilin) can be determined by based on culture or molecular methods. Molecular methods have many advantages over culture. Determination of the antibiotic resistance is important in planning the treatment and in obtaining higher eradication rates.

Özet

Son yıllarda çocuklarda Helicobacter pylori eradikasyon tedavilerinin başarı oranları düşmektedir. Bunun en önemli nedeni kullanılan antibiyotiklere karşı oluşan dirençtir. Direnç mekanizmalarında nokta mutasyonları ve ilaç atım proteinleri önemli rol oynamaktadır. Çocuklarda Helicobacter pylori eradikasyonunda kullanılan antibiyotiklere (klaritromisin, metronidazol ve amoksisilin) karşı oluşan direnç kültür bazlı yöntemlerle ve moleküler yöntemlerle saptanabilir. Moleküler yöntemlerin kültüre göre birçok avantajı bulunmaktadır. Antibiyotik direncinin belirlenmesi tedavinin planlanmasında ve daha yüksek oranda eradikasyon oranları elde edilmesinde önemlidir.

🔖

Cite This Article

ERDUR, C. B., IŞIK, İ. A. (2014). Antibiotic resistance in childhood Helicobacter pylori infection. İzmir Dr. Behçet Uz Çocuk Hastanesi Dergisi, Cilt: 4 - Sayı: 1, 10–14. https://ajindex.com/articles/212615

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997;10:720-741
  2. Rowland M, Bourke B, Drumm B. Helicobacter pylori and Peptic Ulcer Disease. In: Walker’s Pediatric Gastrointestinal Disease, Kleinman RE, Goulet OJ, Sanderson IR, Sherman PM, Shneider P, Vergani GM. Volume 1, Hamilton, BC Decker Inc, 2008: 140-151
  3. Us D, Hascelik G. Seroprevalance of Helicobacter pylori in an asymptomatic Turkish population. J Infect 1998;37:148-180.
  4. Ozen A, Ertem D, Pehlivanoğlu E. Natural history and symptomatology of Helicobacter pylori in childhood and factors determining the epidemiology of infection. J Pediatr Gastroenterol Nutr 2006;42:398-404.
  5. Blaser MJ, Chyou PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer and duodenal ulcer risk. Cancer Res 1995;55:562-565
  6. Feydt-Schmidt A, Kindermann A, Konstantopoulos N, et al. Reinfection rate in children after successful Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 2002;14:1119-1123.
  7. Malfertheiner P, Megraud F, O’Morain C, et al. The European Helicobacter Study Group (EHSG). Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-781.
  8. Vilaichone RK, Mahachai V, Graham DY. Helicobacter pylori diagnosis and management. Gastroenterol Clin North Am 2006;35:229-247.
  9. Oderda G, Schherbakov P, Bontems P, et al. Results from the Pediatric European Register for Treatment of Helicobacter pylori (PERTH). Helicobacter 2007;12:150-156.
  10. Kadayıfçı A, Büyükhatipoğlu H, Savaş MC, Şimşek İ. Eradication of Helicobacter pylori with triple therapy: An epidemiologic analysis of trends in Turkey over 10 years. Clin Ther 2006;11:1960-1966.
  11. Broutet N, Tchamgoue S, Pereira E, et al. Risk factors for failure of Helicobacter pylori therapy-results of an individual data analyses of 2751 patients. Aliment Pharmacol Ther 2003;17:99-109.
  12. Gerrits MM, van Vilet Arnoud HM, Kuipers EJ, Kusters GJ. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implica